Very Late Stent Thrombosis and Late Target Lesion Revascularization
- 31 January 2012
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 125 (4), 562-564
- https://doi.org/10.1161/CIRCULATIONAHA.111.079731
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Very Late Stent Thrombosis and Late Target Lesion Revascularization After Sirolimus-Eluting Stent ImplantationCirculation, 2012
- Stent-Related Cardiac Events Beyond Three Years After Implantation of the Sirolimus-Eluting Stent (from the EVASTENT Patients)The American Journal of Cardiology, 2011
- Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery diseaseCatheterization and Cardiovascular Interventions, 2010
- Incidence and Predictors of Very Late (≥4 Years) Major Cardiac Adverse Events in the DESIRE (Drug-Eluting Stents in the Real World)-Late RegistryJACC: Cardiovascular Interventions, 2010
- Stent Thrombosis in SwedenCirculation: Cardiovascular Interventions, 2009
- Late Clinical Events After Drug-Eluting Stents: The Interplay Between Stent-Related and Natural History-Driven EventsJACC: Cardiovascular Interventions, 2009
- Safety and Efficacy of Drug-Eluting and Bare Metal StentsCell Metabolism, 2009
- Incidence and Correlates of Drug-Eluting Stent Thrombosis in Routine Clinical PracticeJournal of the American College of Cardiology, 2008
- Drug-Eluting Stent ThrombosisJournal of the American College of Cardiology, 2008
- Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysisThe Lancet, 2007